BioCentury
ARTICLE | Emerging Company Profile

Silexon: using AI to disrupt workflows, create assets

Silexon is applying AI to drug discovery, real-world evidence and customized modeling

November 20, 2021 1:37 AM UTC

AI company Silexon is applying artificial intelligence and machine-learning research to drug discovery, real-world evidence and customized modeling.

The Chinese company — whose name is a portmanteau of “silicon” and “exon” — was spun out of Jianyang Zeng’s lab at Tsinghua University in 2018, and has now raised RMB200 million ($31 million). Zeng, who has a Ph.D. from Duke University in computer science, has 15 years’ experience in computational biology. ...

BCIQ Company Profiles

Silexon AI Ltd.